Navigation Links
Health Diagnostic Laboratory, Inc. Announces Diabetes Prevention & Management Panel for Early Detection and Treatment of Disease
Date:5/29/2013

RICHMOND, Va., May 29, 2013 /PRNewswire/ -- Health Diagnostic Laboratory, Inc. has released a new comprehensive panel for the early detection of prediabetes and diabetes that further expands the advanced cardiovascular testing and health management company into the prevention and reversal of a leading cause of heart disease.

(Photo: http://photos.prnewswire.com/prnh/20130529/PH21803-a
(Photo: http://photos.prnewswire.com/prnh/20130529/PH21803-b )

HDL, Inc.'s Diabetes Prevention & Management Panel, or DPMP, uncovers early indicators for type 2 diabetes and offers physicians more advanced, specialized treatment options for the chronic condition. One in three American adults are prediabetic or diabetic, and diabetes alone accounts for 80 percent of all forms of cardiovascular disease. Heart disease is the leading cause of death – and healthcare expenditure – in the U.S.

While conventional measures for diabetes diagnosis only consider a spectrum of indicators such as glucose or HbA1c levels, HDL, Inc.'s DPMP has uncovered nearly one-third more patients who may be at risk for developing type 2 diabetes by looking at deeper, clinical manifestations of the condition.

"DPMP is a novel approach in the early diagnosis of prediabetes and diabetes, allowing us to look at targeted, comprehensive biomarkers, then institute early prevention and targeted therapy to prevent or reverse disease," said Tonya Mallory , HDL, Inc.'s President, CEO and Co-founder. "With early intervention before the detrimental effects of this disease takes root, Health Diagnostic Laboratory will reduce cardiometabolic morbidity and mortality in millions of people, cut healthcare costs, and save lives."

DPMP is a series of tests that in addition to glycemic control look at a patient's insulin resistance and beta cell functionality indicators, the underlying mechanisms that cause diabetes. DPMP allows practitioners to not only uncover early signs of the disease, but offer more specific therapeutic interventions based on the severity of insulin resistance, beta cell dysfunction, or both. In addition, the user-friendly, stoplight color-coded DPMP report motivates and positively engages patients to reverse their fight against the progression of disease.

While traditional methods of diagnosis uncover a little more than half of patients who are predisposed to diabetes, DPMP has found early signs of diabetes in 82 percent of those who are on track to become diabetic. Diabetes and cardiovascular disease make up one-third of the nation's healthcare bill, while the cost of prediabetes and diabetes is expected to rise from $200 billion per year to $500 billion per year by 2020, according to a UnitedHealth study. Risk factors for diabetes include obesity, inactivity, ethnicity, high blood pressure, and smoking; effects of diabetes include stroke, blindness, heart attack, sexual dysfunction, kidney disease, and amputation. Diabetes affects 25.8 million people in the U.S., or 8.3 percent of the population, according to the American Diabetes Association.

"Our nation is facing an epidemic never before seen with the rise of more overweight, obese and inactive Americans. These conditions along with more genetic indicators—found even in healthy people—are primary risk factors for insulin resistance, which can lead to diabetes and associated vascular complications," said Tara Dall , M.D., HDL, Inc.'s Chief Medical Officer. "Insulin resistance is a clear forewarning for diabetes, and diabetes is a major risk factor for heart disease, so the creation of this panel was a natural extension of HDL's capabilities. With DPMP in our arsenal, Health Diagnostic Laboratory is set up to transform the care of patients who would otherwise one day be diagnosed with a life-threatening condition."

About Health Diagnostic Laboratory, Inc. 
Health Diagnostic Laboratory, Inc. (HDL, Inc.) is a leader in health management offering a comprehensive test menu of risk factors and biomarkers for cardiovascular disease, diabetes, and related diseases. Founded in 2008, HDL, Inc.'s systematic approach identifies factors contributing to disease and provides a basis for effective treatment, allowing physicians to more effectively manage patients. Individuals receive a personalized overview of their risk factors along with intensive counseling from expert Clinical Health Consultants at no additional cost, improving compliance and enhancing satisfaction. HDL, Inc. is a CLIA-certified, CAP-accredited laboratory. For more information, visit myhdl.com.

 

 


'/>"/>
SOURCE Health Diagnostic Laboratory, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. MEI Pharma CEO To Present At Jefferies Global Healthcare Conference
2. Abaxis, Inc. to Present at the Jefferies 2013 Global Healthcare Conference
3. Depomed To Present At Jefferies 2013 Global Healthcare Conference
4. VUCA Health Announces Rapid Adoption of its MedsOnCue Digital Patient Engagement Solution Supporting Health Literacy by Innovative Pharmacies across 19 States
5. Premier Healthcare Alliance [GPO] Re-Signs with Sysmex America, Inc. for 15th Consecutive Year
6. AbbVie to Participate in 2013 Jeffries Global Healthcare Conference
7. BioSpecifics Technologies Corp. to Present at Jefferies 2013 Global Healthcare Conference
8. 20th Annual National Senior Health & Fitness Day Set for Wednesday, May 29
9. BioDelivery Sciences to Present at the Jefferies 2013 Global Healthcare Conference
10. Comprehensive Care Corporation CEO Clark A. Marcus Named to Board of Americas Agenda: Health Care for All
11. BD to Present at the Deutsche Bank 38th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... FLINT, Mich. , April 28, 2016 /PRNewswire/ ... transaction . Diplomat Pharmacy, Inc. (NYSE: DPLO), the ... it has signed a definitive agreement to acquire ... Advanced Specialty Pharmacy ("TNH"), a leading specialty pharmacy ... Van Nuys, California . In 2015, ...
(Date:4/28/2016)... Research and Markets has announced ... Market 2016-2020" report to their offering. ... The global plastic surgery products market is expected to ... 2016-2020. , ,The growing adoption of laser in aesthetics ... the market. Lasers are used to treat a broad ...
(Date:4/28/2016)... , April 28, 2016 ... , George Phillips und ... Unternehmens    ArisGlobal®, ein führender ... Sciences, gab heute bekannt, dass neue Führungskräfte ... Unternehmens gestoßen sind, die vielfältige Erfahrungen mitbringen. ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... 2016 , ... Since launching its annual volunteer campaign on ... footwear industry, has broken all previous participation records in its first two weeks ... during the months of April and May, the 2016 Footwear Cares initiative is ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Our bodies are ... way to confront and deal with these stressors is to adopt a more healthful ... good for you. Risa Groux, a certified Holistic Nutritionist and the creator of the ...
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Bernie Siegel, ... seller "LOVE, MEDICINE and MIRACLES") addresses touchy topics related to Death live on ... . Dr. Bernie Siegel, author of a plethora of essential books-to-read for ...
(Date:4/29/2016)... Fort Stewart, GA (PRWEB) , ... April 29, 2016 , ... ... on Monday, May 16, 2016, at its new location in the Exchange Furniture Mall ... including a raffle for a 50-inch Samsung Smart TV. Plus attendees will have the ...
(Date:4/29/2016)... Philadelphia, PA (PRWEB) , ... April 29, 2016 ... ... Pennsylvania announced that student team BioCellection won the $30,000 Perlman Grand Prize of ... Impact Prize, the Gloeckner Undergraduate Award, the Michelson People’s Choice Award, and the ...
Breaking Medicine News(10 mins):